Handelsbanken Fonder AB »

Keros Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $266k 6.7k 39.70
2023-09-30 $214k 6.7k 31.94
2023-06-30 $269k 6.7k 40.15
2023-03-31 $312k 7.3k 42.74
2022-12-31 $351k 7.3k 48.08
2022-03-31 $402k 7.4k 54.32
2021-12-31 $433k 7.4k 58.51